These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 5720636

  • 1. [Contribution to the nutrition-dependent release of insulin in obese maturity-onset diabetics].
    Beringer A, Waldhäusl W.
    Acta Diabetol Lat; 1968; 5(4):566-79. PubMed ID: 5720636
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Insulin-sensitivity and insulin-insensitivity in Indian diabetics as determined by the insulin tolerance test and their influence on the therapeutic response to tolbutamide].
    Singh I, Srivastava MC.
    Acta Diabetol Lat; 1970; 7(5):767-76. PubMed ID: 5526500
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta cell dysfunction in maturity-onset diabetes: reversible loss of glucose-induced insulin secretion with retention of response to arginine.
    Savage PJ, Bennion LJ, Flock EV, Bennett PH.
    Adv Exp Med Biol; 1979; 119():219-25. PubMed ID: 386726
    [No Abstract] [Full Text] [Related]

  • 7. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
    Vague P, Ramahandridona G, Vialettes B, Raymond JP, Vague J.
    Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dietary therapy and insulin secretory response to glucose in adult-onset non-obese diabetic subjects.
    Ichihara K, Shima K, Nonaka K, Tarui S.
    Endocrinol Jpn; 1975 Oct; 22(5):399-408. PubMed ID: 1212982
    [Abstract] [Full Text] [Related]

  • 11. [Phenotypic characteristics and insulin secretion in 25 cases of non-insulin-dependent diabetes mellitus, subtype MODY (maturity onset diabetes in the young people)].
    Muñoz S, Durruty P, García de los Ríos M.
    Rev Med Chil; 1987 May; 115(5):397-403. PubMed ID: 3329377
    [No Abstract] [Full Text] [Related]

  • 12. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A, Catellier C.
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of the effect of glyclopyramide in diabetes mellitus.
    Yamagata S, Goto Y, Oneda A, Kikuchi J, Toyota T.
    Tohoku J Exp Med; 1969 Jun; 98(2):155-69. PubMed ID: 5811101
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E, Beyer J, Schöffling K.
    Dtsch Med Wochenschr; 1974 Mar 01; 99(9):385-8. PubMed ID: 4208186
    [No Abstract] [Full Text] [Related]

  • 18. The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics.
    Dykes JR.
    Postgrad Med J; 1973 May 01; 49(571):318-24. PubMed ID: 4804456
    [Abstract] [Full Text] [Related]

  • 19. [Mild diabetes mellitus in children and young adults. Clinical features and endogenous insulin response].
    Johansen K.
    Nord Med; 1968 Aug 15; 80(33):1080-3. PubMed ID: 5685664
    [No Abstract] [Full Text] [Related]

  • 20. Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.
    Lisch HJ, Sailer S.
    Diabetologia; 1981 Feb 15; 20(2):118-22. PubMed ID: 6781964
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.